Skip to content

QuidelOrtho Corporation QDEL Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Danaher logo
DanaherDHR
Revvity logo
RevvityRVTY
Quest Diagnostics logo
Quest DiagnosticsDGX
Opko Health logo
Opko HealthOPK
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's software and technology licenses, net?
QuidelOrtho Corporation (QDEL) reported software and technology licenses, net of $234.2M in Q1 2026.
How has QuidelOrtho Corporation's software and technology licenses, net changed year-over-year?
QuidelOrtho Corporation's software and technology licenses, net decreased by 13.3% year-over-year, from $270.2M to $234.2M.
What is the long-term trend for QuidelOrtho Corporation's software and technology licenses, net?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's software and technology licenses, net has grown at a 87.9% compound annual growth rate (CAGR), from $19.6M to $244.4M.